cgmp in pharmaceutical industry - An Overview
(d) Any person revealed at any time (both by health care examination or supervisory observation) to possess an clear sickness or open up lesions that will adversely have an affect on the protection or high-quality of drug solutions shall be excluded from direct contact with factors, drug product or